Edwards Lifesciences Corp. closed 26.14% below its 52-week high of $96.12, which the company reached on March 28th.

Spire Wealth Management lessened its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) yesterday and set a price ...

BDX's overall topline in the first quarter of fiscal 2025 continues to benefit from revenue growth in all segments.

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BeiGene (ONC – Research Report) and Embecta ...

In wrapping up the 2023-24 term and embarking on the 2024-25 term, the Supreme Court was asked to decide a number of intellectual property cases. The ...

Mettler-Toledo (MTD) came out with quarterly earnings of $12.41 per share, beating the Zacks Consensus Estimate of $11.69 per share. This compares to earnings of $9.40 per share a year ago. These ...

Find insight on AstraZeneca, Eli Lilly, Siemens Healthineers and more in the latest Market Talks covering Health Care.

Greg Rodetis; Senior Vice President, Treasurer and Head of Investor Relations; Becton Dickinson and Co Thomas Polen; Chairman of the Board, President, Chief Executive Officer; Becton Dickinson and Co ...